Application of response surface methodology to maximize the productivity of scalable automated human embryonic stem cell manufacture
Aim: Commercial regenerative medicine will require large quantities of clinical-specification human cells. The cost and quality of manufacture is notoriously difficult to control due to highly complex processes with poorly defined tolerances. As a step to overcome this, we aimed to demonstrate the u...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Default Article |
Published: |
2013
|
Subjects: | |
Online Access: | https://hdl.handle.net/2134/13171 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|